Mule determines the apoptotic response to HDAC inhibitors by targeted ubiquitination and destruction of HDAC2

Jing Zhang1, Shu Kan, Brian Huang

  • 1Division of Biochemistry and Molecular Biology, Department of Molecular and Cell Biology, University of California at Berkeley, Berkeley, California 94720, USA.

Genes & Development
|October 22, 2011
PubMed

Insights

Mule ubiquitin ligase targets HDAC2 for degradation, impacting cancer cell apoptosis. Mule deficiency compromises responses to DNA damage and HDAC inhibitors, revealing a key regulatory pathway.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Cancer Biology

Background:

  • Histone deacetylases (HDACs) are key epigenetic regulators implicated in human diseases, particularly cancers.
  • HDAC inhibitors (HDACis) show therapeutic promise by inducing cancer cell apoptosis and inhibiting growth.
  • Understanding HDAC regulation is crucial for optimizing HDACi-based cancer therapies.

Purpose of the Study:

  • To investigate the regulatory mechanism of HDAC2.
  • To elucidate the role of Mule (Mcl-1 ubiquitin ligase E3) in HDAC regulation.
  • To determine the impact of Mule deficiency on cellular responses to DNA damage and HDAC inhibitors.

Main Methods:

  • Utilized mouse embryonic fibroblasts deficient in Mule.
  • Assessed the effects of DNA damage and Nutlin-3 treatment on Mule-null cells.
  • Analyzed HDAC2 ubiquitination, degradation, p53 acetylation, and transcriptional activity.

Main Results:

  • Mule deficiency led to HDAC2 accumulation due to impaired ubiquitination and degradation.
  • Mule-null cells exhibited compromised p53 acetylation and activation, hindering apoptosis.
  • Cellular defects in Mule-null cells were partially reversed by HDACis and fully rescued by normalizing HDAC2 levels.

Conclusions:

  • Mule acts as a critical E3 ubiquitin ligase for HDAC2, targeting it for degradation.
  • The Mule-HDAC2 pathway is essential for effective p53-mediated apoptosis in response to DNA damage and HDAC inhibitors.
  • This pathway represents a potential therapeutic target for enhancing cancer treatment strategies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...